145 related articles for article (PubMed ID: 25949435)
1. Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin.
Borman N; Graetz K
NDT Plus; 2010 Aug; 3(4):376-8. PubMed ID: 25949435
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Tinzaparin and unfractionated heparin as anticoagulation on haemodialysis: equal safety, efficacy and economical parity.
Bramham K; Varrier M; Asgari E; Makanjuola D
Nephron Clin Pract; 2008; 110(2):c107-13. PubMed ID: 18824874
[TBL] [Abstract][Full Text] [Related]
3. Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during haemodialysis.
Hoy SM; Scott LJ; Plosker GL
Drugs; 2010 Jul; 70(10):1319-47. PubMed ID: 20568836
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous perforation of acalculous gall bladder presenting as acute abdomen.
Goenka U; Majumder S; Banerjee P; Kapoor N; Nandi S; Sethy PK; Goenka MK
J Emerg Med; 2012 Oct; 43(4):637-40. PubMed ID: 20580518
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of the low molecular weight heparin tinzaparin in haemodialysis.
Simpson HK; Baird J; Allison M; Briggs JD; Rowe PA; Welsh M; Macdougall AI; Grant AC; Lowe GD; Rumley A; Wallace M; Menday AP
Haemostasis; 1996; 26(2):90-7. PubMed ID: 9119288
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
9. Bedside monitoring of anticoagulation in chronic haemodialysis patients treated with tinzaparin.
Pauwels R; Devreese K; Van Biesen W; Eloot S; Glorieux G; Vanholder R; Dhondt A
Nephrol Dial Transplant; 2014 May; 29(5):1092-6. PubMed ID: 24366900
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats.
Lauritzen B; Hedner U; Johansen PB; Tranholm M; Ezban M
J Thromb Haemost; 2008 May; 6(5):804-11. PubMed ID: 18315554
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.
Lim W; Dentali F; Eikelboom JW; Crowther MA
Ann Intern Med; 2006 May; 144(9):673-84. PubMed ID: 16670137
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
13. Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease.
Cheer SM; Dunn CJ; Foster R
Drugs; 2004; 64(13):1479-502. PubMed ID: 15212562
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.
Bara L; Planes A; Samama MM
Br J Haematol; 1999 Feb; 104(2):230-40. PubMed ID: 10050702
[TBL] [Abstract][Full Text] [Related]
15. Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.
Hainer JW; Sherrard DJ; Swan SK; Barrett JS; Assaid CA; Fossler MJ; Cox DS; Williams RM; Pittenger AL; Stephenson CA; Hua TA
Am J Kidney Dis; 2002 Sep; 40(3):531-8. PubMed ID: 12200805
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic type II gall bladder perforation by a gall stone in a CAPD patient.
Göbel T; Kubitz R; Blondin D; Häussinger D
Eur J Med Res; 2011 May; 16(5):213-6. PubMed ID: 21719394
[TBL] [Abstract][Full Text] [Related]
17. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
[TBL] [Abstract][Full Text] [Related]
18. Atypical presentation of cholecystitis with torsion of the gallbladder diagnosed preoperatively in an unusual location.
Kalyanasundaram S; Fernando S
BJR Case Rep; 2022 Jan; 8(1):20210141. PubMed ID: 35136647
[TBL] [Abstract][Full Text] [Related]
19. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
Lord H; Jean N; Dumont M; Kassis J; Leblanc M
Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
[TBL] [Abstract][Full Text] [Related]
20. Review: anticoagulation for haemodialysis.
Suranyi M; Chow JS
Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
